Loading...
非小细胞肺癌分子靶向治疗中EGFR-TKI的耐药机制研究进展
With a greater understanding of tumor biology, novel molecular-targeted strategies that block cancer progression pathways have been evaluated as a new therapeutic approach for treating non-small cell lung cancer (NSCLC). Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such a...
Na minha lista:
| Udgivet i: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
中国肺癌杂志编辑部
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000259/ https://ncbi.nlm.nih.gov/pubmed/22336239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.08 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|